Core Insights - In 2025, Hong Kong's IPO market achieved a record fundraising of $37.4 billion, marking a 231% year-on-year increase and surpassing the total of the previous three years combined [1] - The TMT sector led the market with $34.5 billion in issuance, while the healthcare and biotechnology sectors raised $15.6 billion, with biotechnology alone contributing $6.2 billion [1] - As of early February 2026, over 400 companies are queued for listing, with more than 50 targeting specific chapters of the listing rules, indicating a robust pipeline for the IPO market [1] IPO Performance - The top three companies by fundraising in 2025 were CATL ($41.0 billion), Zijin Mining International ($28.7 billion), and SANY Heavy Industry ($15.5 billion), primarily from sectors like renewable energy, AI, and healthcare [2] - The average first-day price increase for IPOs raising over $100 million was 23.8%, with an average one-month increase of 30.7%, representing the best performance in nearly two decades [4] Foreign Investment Trends - Long-term foreign investment in Hong Kong IPOs surged, with participation rates rising from 10%-15% in early 2024 to 85%-90% in 2025, with expectations to reach 90%-95% in 2026 [4][5] - Major global funds such as Morgan Stanley and Livermore Securities are leading the charge in foreign investments in Hong Kong IPOs [5] Sectoral Insights - The IPO pipeline for 2026 shows a significant focus on AI and software technology, with 22.88% of companies in this category, followed by healthcare and biotechnology at 17.75% [10] - The Hong Kong Stock Exchange has introduced measures to facilitate listings for tech companies, including a "special line" for tech firms and allowing confidential submissions [9] Notable Companies and Underwriters - The top underwriters for 2025 IPOs were CICC (41 projects), CITIC Securities (32 projects), and Huatai Securities (22 projects) [4] - The most anticipated companies for 2026 include Kunlun Chip, Shangmi Technology, and Qunke Technology, indicating a strong interest in new economy sectors [12]

Core Insights - In 2025, Hong Kong's IPO market achieved a record fundraising of $37.4 billion, marking a 231% year-on-year increase and surpassing the total of the previous three years combined [1] - The TMT sector led the market with $34.5 billion in issuance, while the healthcare and biotech sectors raised $15.6 billion, with biotech alone contributing $6.2 billion [1] - As of early February 2026, over 400 companies are lined up for IPOs, with more than 50 targeting specific chapters related to biotech and specialized technology [1] IPO Performance - The top three companies by fundraising in 2025 were CATL ($41.0 billion), Zijin Mining International ($28.7 billion), and SANY Heavy Industry ($15.5 billion), primarily from sectors like renewable energy, AI, and healthcare [2] - The average first-day price increase for IPOs raising over $100 million was 23.8%, with a one-month average increase of 30.7%, the best performance in nearly two decades [5] Foreign Investment Trends - Long-term foreign investment in Hong Kong IPOs surged, with participation rates rising from 10%-15% in early 2024 to 85%-90% in 2025, expected to reach 90%-95% in 2026 [5] - Major foreign institutions like Morgan Stanley and Livermore Securities led the way in underwriting and sponsoring Hong Kong IPOs [5] Industry Focus - The 2026 IPO market is anticipated to be dominated by technology sectors, particularly AI and biotech, reflecting China's advancements in these fields [7][10] - The proportion of companies currently filing for IPOs in AI and software technology is 22.88%, while biotech accounts for 17.75% [10] Notable Companies and Sponsors - The most anticipated IPOs for 2026 include companies like Kunlun Chip, Shangmi Technology, and Qunke Technology, focusing on AI and new economic sectors [14] - The leading sponsors for IPOs in 2025 were CICC with 41 projects, followed by CITIC Securities with 32 projects [4]

Core Viewpoint - In 2025, Hong Kong's stock market achieved a record-breaking IPO fundraising of $37.4 billion, marking a 231% year-on-year increase and surpassing the total of the previous three years combined, showcasing its dominance in the global market [1] IPO Market Performance - The TMT sector led the IPO fundraising with $34.5 billion, followed by the healthcare and biotechnology sector, which raised $15.6 billion, with biotechnology alone contributing $6.2 billion [1] - As of early February 2026, over 400 companies are queued for listing, with more than 50 targeting specific chapters for biotechnology and specialized technology [1] Top IPO Companies - The top three companies by fundraising in 2025 were CATL ($41.006 billion), Zijin Mining International ($28.732 billion), and SANY Heavy Industry ($15.471 billion), primarily from sectors like renewable energy, AI, software and hardware technology, pharmaceuticals, and consumer goods [2] Stock Performance Post-IPO - Newly listed stocks with fundraising of $100 million or more saw an average first-day price increase of 23.8% and an average one-month increase of 30.7%, marking the best performance in nearly two decades [5] Foreign Investment Trends - Long-term foreign investment in Hong Kong IPOs surged, with participation rates rising from 10%-15% in early 2024 to 85%-90% in 2025, with expectations to reach 90%-95% in 2026 [6] - Major foreign institutions like Morgan Stanley and Livermore Securities led the way in underwriting and sponsoring Hong Kong IPOs [6] Anticipated Future Trends - The 2026 IPO market is expected to be a significant year for technology, with a notable increase in companies from AI and biotechnology sectors [19] - The anticipated top ten companies for 2026 include Kunlun Chip, Sunmi Technology, and Qunhe Technology, reflecting a strong focus on AI and new economic sectors [19] Underwriters and Sponsors - In 2025, the top underwriters by project count were CICC (41 projects), CITIC Securities (32 projects), and Huatai Financial (22 projects) [4] - For the ongoing 2026 IPO applications, CICC and CITIC Securities are leading with a market share of 16.23% each [15] Sector Distribution of Upcoming IPOs - The distribution of companies currently in the IPO pipeline is as follows: AI and software technology (22.88%), healthcare and biotechnology (17.75%), and industrial (14.91%) [14]